Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Advanced Proteome Therapeutics Corporation APTCF


Primary Symbol: V.APC.H

Healthcare Biotechnology
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

Recent & Breaking News (TSXV:APC.H)

Advanced Proteome Therapeutics Announces Non-Brokered Private Placement

GlobeNewswire August 3, 2018

Advanced Proteome Therapeutics Announces Collaboration with Noria Pharmaceuticals

GlobeNewswire July 17, 2018

Advanced Proteome Therapeutics Advances its Technological Capability

GlobeNewswire June 18, 2018

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

GlobeNewswire June 6, 2018

Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018

GlobeNewswire May 1, 2018

IIROC Trading Resumption - APC

Canada NewsWire April 17, 2018

Advanced Proteome Therapeutics Announces Appointment of New Board Members

GlobeNewswire April 16, 2018

IIROC Trading Halt - APC

Canada NewsWire April 16, 2018

Advanced Proteome Therapeutics Announces CEO and Director Resignations

GlobeNewswire April 16, 2018

Advanced Proteome Therapeutics and ImmunoBiochem Corporation enter into a Collaboration and Option Agreement

GlobeNewswire February 7, 2018

Advanced Proteome Therapeutics Announces New Patent Grant

MarketWire Canada February 5, 2018

Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum

MarketWire Canada January 31, 2018

Advanced Proteome Therapeutics and Heidelberg Pharma Progress Collaborative Program

Marketwired January 8, 2018

Advanced Proteome Therapeutics Expands Antibody-Drug Conjugate Collaboration

Marketwired November 20, 2017

Advanced Proteome Therapeutics Announces Formation of Business Advisory Committee

Marketwired November 15, 2017

Advanced Proteome Therapeutics to Attend 2017 BIO-Europe Conference to Discuss Partnership Initiatives with Leading Biotechnology Companies

Marketwired November 6, 2017

Advanced Proteome Therapeutics Announces Non-Brokered Private Placement

MarketWire Canada September 7, 2017

Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update

MarketWire Canada July 31, 2017

Advanced Proteome Therapeutics Announces Collaboration to Develop Cancer Therapeutic

MarketWire Canada July 18, 2017

Advanced Proteome Therapeutics Corporation Completes Rights Offering for Gross Proceeds of Approximately $430,000

MarketWire Canada July 11, 2017